Resistance to vasopressin action on the kidney in patients with Cushing's disease.

OBJECTIVE To assess the plasma levels and action of arginine vasopressin (AVP) in patients with Cushing's disease. There are many reports that patients with Addison's disease have increased AVP levels associated with hyponatraemia and hypoosmolality, but none on the dynamics of secretion of this neurohormone during osmolality-based stimulation in patients with chronic hypercortisolism. DESIGN AND SUBJECTS The plasma AVP concentration and the urinary and plasma osmolality after a 7.5-h water deprivation test (WDT) were evaluated in 13 patients with Cushing's disease and 15 normal (control) individuals. In patients with Cushing's disease we also assessed the urinary osmolality in response to 10 micrograms i.v. desmopressin (DDAVP) administered at the end of the WDT. RESULTS At the end of the WDT, urinary osmolality was significantly lower in patients with Cushing's disease (511.5 +/- 148.5 mOsm/l) than in the normal subjects (981.1 +/- 107.1 mOsm/l, P < 0.001), whereas plasma osmolality did not differ between the two groups. Consequently, the urine/plasma osmolality ratio (Uosm/Posm) was lower in patients with Cushing's disease than in normal individuals (1.8 +/- 0.5 compared with 3.4 +/- 0.4, P < 0.001). The AVP concentration also was greater (7.3 +/- 3.1 pmol/l) in those with Cushing's disease than in the controls (3.9 +/- 2.3 pmol/l, P < 0.005). After administration of DDAVP to the hypercortisolaemic patients, the urinary osmolality attained (718.0 +/- 200.0 mOsm/l) was still lower than that in the normal group at the end of WDT (P < 0.005). CONCLUSIONS Patients with Cushing's disease presented higher AVP levels and smaller Uosm/Posm ratios than normal subjects. After DDAVP, the patients with Cushing's disease were unable to concentrate the urine adequately. These data suggest that the kidney shows resistance to the action of both endogenous and exogenous AVP in patients with Cushing's disease.

[1]  J. Doppman,et al.  Inferior petrosal sinus arginine vasopressin concentrations in normal volunteers and patients with Cushing's disease. , 1996, The Journal of clinical endocrinology and metabolism.

[2]  R. Fahlbusch,et al.  Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. , 1996, The Journal of clinical endocrinology and metabolism.

[3]  L. Mahan,et al.  Extrapituitary expression of the rat V1b vasopressin receptor gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  X. Bertagna,et al.  Cloning and characterization of the human V3 pituitary vasopressin receptor , 1994, FEBS letters.

[5]  T. Sugimoto,et al.  Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. , 1994, The Journal of biological chemistry.

[6]  T. Yamaji,et al.  Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency. , 1993, The Journal of clinical endocrinology and metabolism.

[7]  J. Livesey,et al.  The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse. , 1993, Endocrinology.

[8]  B. Mendonca,et al.  The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome , 1993, Clinical endocrinology.

[9]  J. Mol,et al.  Osmoregulation of systemic vasopressin release during long-term glucocorticoid excess: a study in dogs with hyperadrenocorticism. , 1991, Acta endocrinologica.

[10]  S. Nussey,et al.  Corticotrophin releasing hormone (CRH1–41) stimulates the secretion of adrenocorticotrophin, vasopressin and oxytocin but not adrenocorticotrophin precursors: evidence from petrosal sinus sampling in man , 1991, Clinical endocrinology.

[11]  H. Raff,et al.  Feedback control of vasopressin and corticotrophin secretion in conscious dogs: effect of hypertonic saline. , 1989, The Journal of endocrinology.

[12]  R. Harrison,et al.  Demonstration of glucocorticoid receptor‐like immunoreactivity in glucocorticoid‐sensitive vasopressin and corticotropin‐releasing factor neurons in the hypothalamic paraventricular nucleus , 1988, Journal of neuroscience research.

[13]  T. Janáky,et al.  Osmoregulation of arginine-8-vasopressin secretion in primary hypothyroidism and in Addison's disease. , 1987, Acta endocrinologica.

[14]  L. G. Davis,et al.  Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleus of the rat. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. M. Hays.  Alteration of luminal membrane structure by antidiuretic hormone. , 1983, The American journal of physiology.

[16]  T. Dousa,et al.  Concentrating defect in the adrenalectomized rat. Abnormal vasopressin-sensitive cyclic adenosine monophosphate metabolism in the papillary collecting duct. , 1983, The Journal of clinical investigation.

[17]  A. Spital.  Hyponatremia in Adrenal Insufficiency: Review of Pathogenetic Mechanisms , 1982, Southern medical journal.

[18]  J. Kokko,et al.  Urinary concentrating defect of adrenal insufficiency. Permissive role of adrenal steroids on the hydroosmotic response across the rabbit cortical collecting tubule. , 1980, The Journal of clinical investigation.

[19]  J. Dingman,et al.  Increased plasma arginine vasopressin in clinical adrenocortical insufficeincy and its inhibition by glucosteroids. , 1967, The Journal of clinical investigation.

[20]  C. Kleeman,et al.  Mechanisms of impaired water excretion in adrenal and pituitary insufficiency. I. The role of altered glomerular filtration rate and solute excretion. , 1958, The Journal of clinical investigation.